Please login to the form below

Not currently logged in
Email:
Password:

Tonix appoints head of clinical development

Donald Kellerman has experience at Allergan, Map, Inspire and Glaxo Wellcome

Tonix Pharmaceuticals has appointed Dr Donald Kellerman to head the strategy and execution of its clinical programmes.

Dr Kellerman brings 30 years of industry experience to his new role as senior VP, clinical development and regulatory affairs.

This includes his most recent role as VP, scientific affairs for Allergan's inhalation products business. He took on this role after his previous company, Map Pharmaceuticals, was taken over by Allergan in 2013.

At Map, Dr Kellerman served as senior VP, clinical development and medical affairs at Map Pharmaceuticals having joined the company in 2008 from Inspire Pharmaceuticals.

He also has experience at GlaxoWellcome as director of respiratory clinical research.

3rd April 2014

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics